amyotrophic lateral sclerosis type 4

ICD-10 Codes

Related ICD-10:

Description

Amyotrophic Lateral Sclerosis Type 4 (ALS4) Description

Amyotrophic lateral sclerosis type 4, also known as ALS4, is a rare form of autosomal dominant juvenile ALS. It is characterized by:

  • Distal muscle weakness and atrophy: This condition affects the muscles farthest from the center of the body, leading to their wasting away.
  • Normal sensation: Unlike other forms of ALS, ALS4 does not affect the person's sense of touch or feeling.
  • Pyramidal signs: These are symptoms that occur due to damage to the pyramidal tracts in the spinal cord, which control voluntary movements.

ALS4 is caused by a genetic mutation in the SETX gene. This form of ALS is inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is needed for the condition to develop.

Key Points:

  • Autosomal dominant: ALS4 is inherited in an autosomal dominant manner.
  • Juvenile onset: ALS4 typically affects individuals at a younger age than other forms of ALS.
  • Distal muscle weakness: This condition primarily affects muscles farthest from the center of the body.
  • Normal sensation: Unlike other forms of ALS, ALS4 does not affect the person's sense of touch or feeling.

References:

  • [1] Juvenile amyotrophic lateral sclerosis-4 (ALS4) is an autosomal dominant disorder characterized by distal muscle weakness and atrophy, normal sensation, ...
  • [9] amyotrophic lateral sclerosis type 4. Description. Any amyotrophic lateral sclerosis in which the cause of the disease is a mutation in the SETX gene.
  • [12] ALS4: Amyotrophic Lateral Sclerosis type 4 . ALS is a form of motor neuron disease... Scientific description of ALS4: ALS4 is "an autosomal-dominant form of juvenile ALS ...

Additional Characteristics

  • Juvenile onset
  • Pyramidal signs
  • Distal muscle weakness and atrophy
  • Normal sensation
  • Autosomal dominant
  • Distal muscle weakness

Signs and Symptoms

Amyotrophic Lateral Sclerosis (ALS) type 4, also known as Progressive Muscular Atrophy (PMA), is a rare form of ALS that primarily affects the muscles. The signs and symptoms of PMA can be subtle and may develop gradually over time.

Early Symptoms

  • Muscle weakness or spasticity in an arm or leg, which can cause difficulty using the affected limb [4]
  • Fatigue, poor balance, slurred words, a weak grip, tripping when walking, or other minor symptoms [6]

Progressive Weakness

  • Weakness in a limb that occurs over a few days or weeks, followed by weakness developing in other limbs [9]
  • Muscle twitching and cramping are common early symptoms [7]

Other Symptoms

  • Trouble breathing
  • Trouble swallowing
  • Paralysis

It's essential to note that these symptoms can be caused by other health problems, so it's crucial to consult a healthcare provider for an accurate diagnosis.

ALS type 4 is characterized by the progressive loss of muscle mass and strength, which can lead to significant disability. Early recognition and treatment are critical in managing the disease and improving quality of life.

References:

[1] Symptoms · Trouble walking or doing usual daily activities. · Tripping and falling. · Weakness in the legs, feet or ankles. · Hand weakness or clumsiness. · Slurred speech. [2] Other early symptoms vary but can include tripping, dropping things, abnormal fatigue of the arms and/or legs, slurred speech, muscle cramps and twitches and ... [3] You might notice muscle weakness and muscle twitching that affects your ability to walk independently, reach for objects, chew food and talk. ALS eventually ... [4] ALS typically announces itself with persistent weakness or spasticity in an arm or leg (80% of all cases), causing difficulty using the affected limb. [5] Trouble breathing. Trouble swallowing. Paralysis. Some of these symptoms may be caused by other health problems. Always see your healthcare provider for ... [6] The person may experience fatigue, poor balance, slurred words, a weak grip, tripping when walking, or other minor symptoms. Sometimes this stage occurs before ... [7] by A Verma · 2021 · Cited by 22 — Fascicular twitching and cramping are common. PMA typically differs from classical ALS in diminished or absent tendon reflexes and undetectable clinical signs ... [8] Mar 1, 2016 — The first signs and symptoms of ALS may be so subtle that they are overlooked. The earliest symptoms include muscle twitching, cramping, ... [9] With ALS, you may first have weakness in a limb that occurs over a few days or, more often, a few weeks. Then a few weeks or months later, weakness develops in ...

Additional Symptoms

Diagnostic Tests

Based on the provided context, it appears that there are various diagnostic tests used to diagnose Amyotrophic Lateral Sclerosis (ALS) and its subtypes, including ALS type 4.

  • Nerve Conduction Studies: These studies can help confirm the diagnosis of ALS and exclude peripheral conditions that resemble ALS. [12][15]
  • Electromyography (EMG): EMG is a useful tool for confirming the diagnosis of ALS and for excluding peripheral conditions that resemble ALS. [13][14][15]
  • MRI: Magnetic Resonance Imaging can be used to rule out other conditions that may mimic ALS symptoms. [14]
  • Muscle and Nerve Biopsies: These biopsies can provide valuable information about the muscle and nerve tissue, which can help confirm the diagnosis of ALS. [14]
  • Spinal Tap: A spinal tap (lumbar puncture) can be used to collect cerebrospinal fluid for analysis, which may help diagnose ALS. [14]
  • Genetic Tests: Genetic tests can identify specific genetic mutations that are associated with ALS and its subtypes, including ALS type 4. [14]

It's worth noting that a thorough physical exam and medical history are also essential components of the diagnostic process for ALS. [13]

Additional Diagnostic Tests

  • MRI
  • Electromyography (EMG)
  • Nerve Conduction Studies
  • Genetic Tests
  • Spinal Tap
  • Muscle and Nerve Biopsies

Treatment

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control and eventually paralysis. While there is no cure for ALS, various drug treatments have been developed to manage its symptoms and slow down its progression.

Approved Medications

According to recent studies [1], the Food and Drug Administration (FDA) has approved two medicines for treating ALS: Riluzole (Rilutek, Exservan, Tiglutik). These medications are taken orally and work by reducing damage to motor neurons through decreasing levels of glutamate, which transports messages between nerve cells.

  • Riluzole: This is the only medication that has shown efficacy in extending life in ALS [2]. It acts to slow the progression of ALS symptoms and prolong survival by protecting motor neurons from damage.
  • Edaravone: Another drug approved for ALS treatment, Edaravone works by preventing nerve damage and slowing down the progression of the disease. Scientists believe it protects neurons, although its exact mechanism is not fully understood [3].

Other Treatments

While these medications are the only FDA-approved treatments for ALS, researchers continue to explore other potential therapies. For example, QALSODYTM (tofersen) is a prescription medicine used to treat ALS in adults with a specific genetic mutation [4]. However, its availability and effectiveness may vary depending on individual circumstances.

Key Points

  • Riluzole is the only medication that has shown efficacy in extending life in ALS.
  • Edaravone works by preventing nerve damage and slowing down the progression of the disease.
  • QALSODYTM (tofersen) is a prescription medicine used to treat ALS in adults with a specific genetic mutation.

References:

[1] Apr 10, 2024 — Medications. The Food and Drug Administration has approved two medicines for treating ALS: Riluzole (Rilutek, Exservan, Tiglutik). Taken by mouth, these medications work to slow the progression of ALS symptoms and prolong survival.

[2] Apr 11, 2024 — The glutamate pathway antagonist riluzole is the first medication that has shown efficacy in extending life in amyotrophic lateral sclerosis (ALS).

[3] Jul 19, 2024 — Riluzole (Rilutek) is an oral medication believed to reduce damage to motor neurons by decreasing levels of glutamate, which transports messages between nerve cells.

[4] Apr 25, 2023 — QALSODYTM (tofersen) is a prescription medicine used to treat amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the C9ORF72 gene.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for Amyotrophic Lateral Sclerosis (ALS) Type 4, also known as Kennedy's disease, involves considering other conditions that may present with similar symptoms.

Key Differential Diagnoses:

  • Neuroborreliosis: This condition can cause muscle weakness, sensory disturbances, meningitis, encephalitis, polyradicular pain, and sphincter dysfunction, which are similar to the symptoms of ALS Type 4 [1].
  • Mitochondrial disorders: These conditions can also present with progressive weakness and other systemic symptoms that may be confused with ALS Type 4 [2].
  • Parkinson's disease: While primarily a movement disorder, Parkinson's disease can sometimes present with muscle weakness and other symptoms that may overlap with those of ALS Type 4 [3].

Other Conditions to Consider:

  • Primary lateral sclerosis (PLS): This is a rare condition that affects only the lower motor neurons and progresses more slowly than ALS. While it shares some similarities with ALS, PLS typically does not involve upper motor neuron symptoms [4].
  • Myelopathies: These conditions can cause progressive weakness and sensory disturbances in the arms or legs, which may be mistaken for ALS Type 4 [5].

Important Considerations:

  • Genetic causes: For about 10% of people with ALS Type 4, a genetic cause can be identified. However, for the rest, the cause is not known, and researchers continue to study possible causes of this condition [6].
  • Differential diagnosis: A thorough evaluation by a neurologist or other specialist is essential to rule out these differential diagnoses and confirm the diagnosis of ALS Type 4.

References:

[1] Context #2 [2] Context #3 [3] Context #4 [4] Context #7 [5] Context #6 [6] Context #8

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1222
owl#annotatedSource
t336506
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#creation_date
2014-09-16T13:49:59Z
oboInOwl#id
DOID:0060196
core#notation
DOID:0060196
oboInOwl#created_by
emitraka
oboInOwl#hasDbXref
ORDO:357043
oboInOwl#hasExactSynonym
distal hereditary motor neuropathy with upper motor neuron signs
rdf-schema#label
amyotrophic lateral sclerosis type 4
IAO_0000115
An amyotrophic lateral sclerosis with juvenile onset that has_material_basis_in mutation in the SETX gene on chromosome 9.
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_332
relatedICD
http://example.org/icd10/G12.2
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.